Current Oncology (Nov 2024)

Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. <i>Curr. Oncol.</i> 2023, <i>30</i>, 6097–6110

  • Alberto Alvarado-Miranda,
  • Fernando Ulises Lara-Medina,
  • Wendy R. Muñoz-Montaño,
  • Juan W. Zinser-Sierra,
  • Paula Anel Cabrera Galeana,
  • Cynthia Villarreal Garza,
  • Daniel Sanchez Benitez,
  • Jesús Alberto Limón Rodríguez,
  • Claudia Haydee Arce Salinas,
  • Alberto Guijosa,
  • Oscar Arrieta

DOI
https://doi.org/10.3390/curroncol31110529
Journal volume & issue
Vol. 31, no. 11
pp. 7177 – 7179

Abstract

Read online

In the original publication [...]

Keywords